Published in Postgrad Med J on June 01, 1976
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Attenuation of human influenza A viruses. Br Med J (1969) 1.90
Vaccination in the control of influenza. Interim report to the Director of the Public Health Laboratory Service on a Collaborative Study with the Post Office. Lancet (1974) 1.18
The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) (1972) 7.42
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
A single radial haemolysis technique for the measurement of influenza antibody. J Gen Virol (1975) 2.62
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Attenuation of human influenza A viruses. Br Med J (1969) 1.90
Recombinant influenza-A viruses as live vaccines for man. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1971) 1.88
A comparative study of attenuated influenza viruses. Bull World Health Organ (1971) 1.81
Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet (1975) 1.74
Further trials of live influenza vaccine. Br Med J (1966) 1.58
Measurement of antibody to influenza virus neuraminidase by single radial hemolysis in agarose gels. Infect Immun (1976) 1.50
Virulence for man of a human influenza-A virus antigenically similar to "classical" swine viruses. Lancet (1976) 1.43
Prophylaxis of influenza with a synthetic isoquinoline. Lancet (1968) 1.38
Antigenic characteristics of swine influenza virus closely related to human Hong Kong strain and results of experimental infection in volunteers. Lancet (1971) 1.31
Antibody responses to and efficacy of an inactivated spray vaccine. Bull World Health Organ (1969) 1.29
Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet (1981) 1.21
Laboratory characteristics of attenuated influenza viruses. Bull World Health Organ (1969) 1.13
RNAs of influenza virus recombinants derived from parents of known virulence for man. Arch Virol (1977) 1.10
Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Nature (1978) 1.09
Spectrum and characteristics of the virus-inhibitory action of two isoquinoline derivatives. Antimicrob Agents Chemother (Bethesda) (1967) 1.05
Live viruses for immunization against influenza. Prog Med Virol (1975) 1.04
Formation of antibody to matrix protein in experimental human influenza A virus infections. Infect Immun (1978) 1.04
Growth and pathogenicity of influenza viruses in organ cultures of ciliated epithelium. I. Experiments in ferret and human tissue. Arch Gesamte Virusforsch (1974) 1.01
Protection of volunteers against challenge with A-Hong Kong-68 influenza virus by a new adamantane compound. Lancet (1972) 0.95
Use of recombination in the production of influenza vaccine strains. Postgrad Med J (1973) 0.95
Relation between blood groups and resistance to infection with influenza and spome picornaviruses. Nature (1968) 0.93
Prospects for immunization against influenza by the use of living vaccines. Proc R Soc Med (1969) 0.92
Influenza virus plaque formation in different species of cell monolayers. J Gen Virol (1974) 0.88
The efficacy of live and inactivated vaccines of Hong Kong influenza virus in an industrial community. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. J Hyg (Lond) (1973) 0.88
Human trials with wild-type H1N1 and recombinant H3N2-H1N1 influenza A viruses of 1977-1978. Infect Immun (1980) 0.86
The production of live attenuated influenza A strains by recombination with A/Okuda/57 (H2N2). Postgrad Med J (1976) 0.85
Some studies on the selection and efficiency of live influenza vaccine viruses. Bull World Health Organ (1969) 0.82
A re-examination of the single radial haemolysis technique for the assay of influenza anti-neuraminidase antibodies in human sera. Arch Virol (1980) 0.81
Selection of influenza B virus recombinants and their testing in humans for attenuation and immunogenicity. Infect Immun (1977) 0.81
Use of single radial immunodiffusion test for serological studies in volunteers inoculated with live attenuated influenza virus. J Hyg (Lond) (1974) 0.81
In vitro antiviral activity and preliminary clinical trials of a new adamantane compound. Antimicrob Agents Chemother (1973) 0.81
Laboratory characteristics of influenza A viruses attenuated for man. Arch Gesamte Virusforsch (1970) 0.80
Plaque formation by influenza B viruses in primary calf kidney cell monolayes. J Gen Virol (1971) 0.80
Further studies in man of Hsw1N1 influenza viruses. J Med Virol (1980) 0.78
The formation of interferon during acute respiratory virus infection of volunteers. Arch Gesamte Virusforsch (1971) 0.77
Plaquing characteristics of influenza A virus recombinants of defined genetic composition. Brief report. Arch Virol (1982) 0.75
Experimental infection of human volunteers with a swine influenzavirus antigenically related to the human A-Hong Kong-68 virus. Bull World Health Organ (1972) 0.75
A therapeutic study of an adamantane spiro compound in experimental influenza A infection in man. J Antimicrob Chemother (1975) 0.75
Influenza A neuraminidase antibodies in children and young adults studied by serum absorption. J Hyg (Lond) (1977) 0.75
Reactions and antibody response to live influenza vaccine prepared from the Iksha (A2) strain: (A report to the Medical Research Council by their Committee on Influenza and other Respiratory Virus Vaccines). J Hyg (Lond) (1967) 0.75
Vaccination against influenza. Practitioner (1975) 0.75
The present status of influenza vaccination. Practitioner (1972) 0.75
Trials of live influenza A recombinants in man during natural antigenic change in 1971-1976. Med Microbiol Immunol (1978) 0.75
Experiments in the preparation of live influenza B vaccines. Dev Biol Stand (1978) 0.75
Upper respiratory infections. Practitioner (1983) 0.75
Myxoviruses. Dev Biol Stand (1975) 0.75